Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's Disease : A multicenter 5-year study

Journal article

Peer reviewed

G BLOCK, C LISS, S REINES, J IRR and D NIBBELINK

European neurology, Vol.37(1), pp.23-27

1997

PMID: 9018028

Abstract

Biological and medical sciences

Anticonvulsants. Antiepileptics. Antiparkinson agents

Medical sciences

Neuropharmacology

Pharmacology. Drug treatments

13 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.52 Neurodegenerative Diseases; 1.52.67 Parkinson's Disease
Web Of Science research areas: Clinical Neurology; Neurosciences
ESI research areas: Neuroscience & Behavior

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's Disease : A multicenter 5-year study
Creators: G BLOCK - Merck & Co., Inc., Merck Research Laboratories, Blue Bell, Pa., United States
C LISS - Merck & Co., Inc., Merck Research Laboratories, Blue Bell, Pa., United States
S REINES - Merck & Co., Inc., Merck Research Laboratories, Blue Bell, Pa., United States
J IRR - DuPont Pharma, DuPont Merck Plaza, Wilmington, Del., United States
D NIBBELINK - DuPont Pharma, DuPont Merck Plaza, Wilmington, Del., United States
Publication Details: European neurology, Vol.37(1), pp.23-27
Publisher: Karger; Basel
Language: English
Resource Type: Journal article
PMID: 9018028
Record Identifier: 991031575462202976